Patients with Guillain-Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness. In Europe and the USA, around 1 to 2 cases per 100,000 people occur every year.
GBS usually begins with weakness and tingling in the legs, which can then spread to the arms and upper body, making it difficult to walk or move. In severe cases, paralysis can affect the breathing muscles. Although GBS is considered an autoimmune disease, the underlying mechanisms remain largely unknown, making an accurate diagnosis and effective treatment a challenge.
A recent study published in the renowned journal Nature, now uncovers a pivotal aspect of GBS pathophysiology. The work investigated autoimmune factors that are potentially responsible for this illness in close collaboration with clinical scientists.
By employing sensitive experimental approaches, the group was able to reveal that in GBS patients, specific cells of the immune system known as T lymphocytes invade the nerve tissue and target the insulating covering of nerve fibres called myelin.
Normally, T lymphocytes play a vital role in our immune system by identifying and eliminating threats like infections and abnormal cells. However, in rare cases, they can mistakenly attack the body’s own tissues, leading to autoimmune diseases.
“We found that these autoreactive T lymphocytes were exclusive to patients with a type of GBS characterised by nerve demyelination and showed a specific disease-associated signature, distinguishing them from healthy individuals,” the senior author explains. These findings mark the first evidence of the contribution of autoreactive T lymphocytes to the disease in humans.
Furthermore, the researchers identified T lymphocytes reactive to both self-antigens of peripheral nerves (myelin) and viral antigens in a subset of post-viral GBS patients, supporting a direct link between disease development and triggers of a preceding infection.
Current treatments are effective for many GBS patients, but they lack specificity, and around 20% of patients remain severely disabled or die. Overall, the work of the research team offers novel insights into our understanding of GBS, opening avenues for further investigations on larger patient groups to decipher immune mechanisms in different GBS variants. This new knowledge could lead to targeted therapies for specific GBS subtypes, potentially improving patient care.
https://www.nature.com/articles/s41586-023-06916-6
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fmassively-parallel_3&filter=22
Autoreactive T cells target peripheral nerves in Guillain-Barré syndrome
- 800 views
- Added
Latest News
Alzheimer's disease symptom…
By newseditor
Posted 27 Jun
Gene-regulatory networks in…
By newseditor
Posted 27 Jun
How apoE influences Aβ aggr…
By newseditor
Posted 26 Jun
How do plants break down da…
By newseditor
Posted 26 Jun
A new tool for neurological…
By newseditor
Posted 26 Jun
Other Top Stories
A new protein implicated in the progression of Alzheimer's
Read more
High air pollution exposure in 1-year-olds linked to structural bra…
Read more
Preventing, healing tooth decay with a bioactive peptide
Read more
Huntingtin plays a crucial role in synapse formation
Read more
Blood-brain barrier restoration is necessary for the treatment of d…
Read more
Protocols
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Deciphering spatial domains…
By newseditor
Posted 23 Jun
High-throughput volumetric…
By newseditor
Posted 21 Jun
Bioengineered human colon o…
By newseditor
Posted 14 Jun
Development of an efficient…
By newseditor
Posted 12 Jun
Publications
Immunometabolism in atheros…
By newseditor
Posted 27 Jun
Long-range inhibitory neuro…
By newseditor
Posted 27 Jun
The microtubule-dynamin bin…
By newseditor
Posted 27 Jun
High sugar diet-induced fat…
By newseditor
Posted 27 Jun
Brain repair mechanisms aft…
By newseditor
Posted 27 Jun
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar